Multimodality therapy is recommended for limited-stage combined small cell esophageal carcinoma

OncoTargets and Therapy

Volumn 8, Issue , 2015, Pages 437-444

  Wang, Huan Huan ^a   Zaorsky, Nicholas G ^b   Meng, Mao Bin ^a   Wu, Zhi Qiang ^a   Zeng, Xian Liang ^a   Jiang, Bo ^a   Jiang, Chao ^a   Zhao, Lu Jun ^a   Yuan, Zhi Yong ^a   Wang, Ping ^a  

^a TIANJIN MEDICAL UNIVERSITY   (China)

^b FOX CHASE CANCER CENTER   (United States)

Author keywords

Chemotherapy; Esophageal neoplasm; Radiation therapy; Small cell; Surgery

Indexed keywords

CARBOPLATIN; CISPLATIN; ETOPOSIDE; FLUOROURACIL; IRINOTECAN;

ADULT; ARTICLE; CANCER LOCALIZATION; CANCER PROGNOSIS; CANCER RADIOTHERAPY; CANCER SURGERY; CANCER SURVIVAL; CONTROLLED STUDY; ESOPHAGUS CARCINOMA; FEMALE; HUMAN; LIMITED STAGE COMBINED SMALL CELL ESOPHAGEAL CARCINOMA; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; MULTIMODALITY CANCER THERAPY; MULTIPLE CYCLE TREATMENT; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PREDICTION; SMALL CELL CARCINOMA; TREATMENT FAILURE; TREATMENT RESPONSE;

EID: 84922978689     PISSN: 11786930     EISSN: 11786930     Source Type: Journal    
DOI: 10.2147/OTT.S76048     Document Type: Article

References (39)

1. Huncharek M, Muscat J. Small cell carcinoma of the esophagus. The Massachusetts General Hospital experience, 1978 to 1993. Chest. 1995; 107(1):179–181.
2. Craig SR, Carey FA, Walker WS, Cameron EW. Primary small cell cancer of the esophagus. J Thorac Cardiovasc Surg. 1995;109:284–288.
3. Briggs JC, Ibrahim NB. Oat cell carcinomas of the oesophagus: a clinico-pathological study of 23 cases. Histopathology. 1983;7(2):261–277.
4. Casas F, Ferrer F, Farrús B, Casals J, Biete A. Primary small cell carcinoma of the esophagus: a review of the literature with emphasis on therapy and prognosis. Cancer. 1997;80(8):1366–1372.
5. Pantvaidya GH, Pramesh CS, Deshpande MS, Jambhekar NA, Sharma S, Deshpande RK. Small cell carcinoma of the esophagus: the Tata Memorial Hospital experience. Ann Thorac Surg. 2002;74(6):1924–1927.
6. Brenner B, Tang LH, Klimstra DS, Kelsen DP. Small-cell carcinomas of the gastrointestinal tract: a review. J Clin Oncol. 2004;22(13): 2730–2739.
7. Lv J, Liang J, Wang J, et al. Primary small cell carcinoma of the esophagus. J Thorac Oncol. 2008;3(12):1460–1465.
8. Meng MB, Zaorsky NG, Jiang C, et al. Radiotherapy and chemotherapy are associated with improved outcomes over surgery and chemotherapy in the management of limited-stage small cell esophageal carcinoma. Radiother Oncol. 2013;106(3):317–322.
9. Takubo K, Nakamura K, Sawabe M, et al. Primary undifferentiated small cell carcinoma of the esophagus. Hum Pathol. 1999;30(2):216–221.
10. Maru DM, Khurana H, Rashid A, et al. Retrospective study of clinicopathologic features and prognosis of high-grade neuroendocrine carcinoma of the esophagus. Am J Surg Pathol. 2008;32(9):1404–1411.
11. Gamliel Z, Krasna MJ. Multimodality treatment of esophageal cancer. Surg Clin North Am. 2005;85:621–630.
12. Samson DJ, Seidenfeld J, Simon GR, et al; American College of Chest Physicians. Evidence for management of small cell lung cancer: ACCP evidence-based clinical practice guidelines (2nd edition). Chest. 2007; 132(3 Suppl):314S–323S.
13. Sgambato A, Casaluce F, Maione P, et al. Medical treatment of small cell lung cancer: state of the art and new development. Expert Opin Pharmacother. 2013;14(15):2019–2031.
14. Sasajima K, Hayashi N, Yamashita K, Onda M, Takubo K. Oat cell carcinoma of the esophagus with multiple differentiation. J Clin Gastroenterol. 1988;10(6):667–671.
15. Walker SJ, Steel A, Cullen MH, Matthews HR. Treatment of oesophageal small cell carcinoma by combined chemotherapy and surgical resection: report of two cases and review of published cases. Thorax. 1989;44(9):751–752.
16. Mori M, Matsukuma A, Adachi Y, et al. Small cell carcinoma of the esophagus. Cancer. 1989;63(3):564–573.
17. Muto I, Nishimaki T, Aizawa K, Suzuki T, Tanaka O, Hatakeyama K. Primary small cell carcinoma of the esophagus: report of a case. Surg Today. 1995;25(9):830–833.
18. Casas F, Farrús B, Daniels M, et al. Six-year follow-up of primary small cell carcinoma of the esophagus showing a complete response: a case report. Jpn J Clin Oncol. 1996;26(3):180–184.
19. Nishimaki T, Suzuki T, Nakagawa S, Watanabe K, Aizawa K, Hatakeyama K. Tumor spread and outcome of treatment in primary esophageal small cell carcinoma. J Surg Oncol. 1997;64(2):130–134.
20. Poynton AR, Walsh TN, Kelly A, Harney M, Stuart R, Daly PA, Hennessy TP. Small cell carcinoma of the oesophagus. Eur J Surg Oncol. 1997;23(6):509–512.
21. Shimizu K, Takiyama W, Mandai K, Tanada M, Kawabuchi Y, Heike Y. Undifferentiated carcinoma with lymphoid infiltration of the esophagus: a case report. Jpn J Clin Oncol. 1999;29(10):494–497.
22. Mitani M, Kuwabara Y, Shinoda N, Sato A, Fujii Y. Long-term survivors after the resection of limited esophageal small cell carcinoma. Dis Esophagus. 2000;13(3):259–261.
23. Makino H, Tajiri T, Onda M, et al. Effectiveness of preoperative chemotherapy using carboplatin (CBDCA) and surgery against an esophageal small cell carcinoma. Dis Esophagus. 2002;15(3):237–241.
24. Yamamoto J, Ohshima K, Ikeda S, Iwashita A, Kikuchi M. Primary esophageal small cell carcinoma with concomitant invasive squamous cell carcinoma or carcinoma in situ. Hum Pathol. 2003;34(11): 1108–1115.
25. Furihata M, Ono Y, Fujimori T, et al. Esophageal small cell carcinoma effectively treated by cisplatin and irinotecan. Esophagus. 2006;3(2): 61–64.
26. Yun JP, Zhang MF, Hou JH, et al. Primary small cell carcinoma of the esophagus: clinicopathological and immunohistochemical features of 21 cases. BMC Cancer. 2007;7:38.
27. Ku GY, Minsky BD, Rusch VW, Bains M, Kelsen DP, Ilson DH. Small-cell carcinoma of the esophagus and gastroesophageal junction: review of the Memorial Sloan-Kettering experience. Ann Oncol. 2008;19(3): 533–537.
28. Chin K, Baba S, Hosaka H, et al. Irinotecan plus cisplatin for therapy of small-cell carcinoma of the esophagus: report of 12 cases from single institution experience. Jpn J Clin Oncol. 2008;38(6):426–431.
29. Bibeau F, Chateau MC, Guiu M, et al. Small cell carcinoma with concomitant adenocarcinoma arising in a Barrett’s oesophagus: report of a case with a favourable behaviour. Virchows Arch. 2008;452(1): 103–107.
30. Terada T, Maruo H. Esophageal combined carcinomas: Immunohoistochemical and molecular genetic studies. World J Gastroenterol. 2012;18(13):1545–1551.
31. Li J, Chen X, Shen Y, et al. A rare collision tumor of squamous carcinoma and small cell carcinoma in esophagus involved with separate lymph nodes: a case report. J Thorac Dis. 2013;5(5):E203–E206.
32. Kukar M, Groman A, Malhotra U, et al. Small cell carcinoma of the esophagus: a SEER database analysis. Ann Surg Oncol. 2013;20(13): 4239–4244.
33. Vos B, Rozema T, Miller RC, et al. Small cell carcinoma of the esophagus: a multicentre Rare Cancer Network study. Dis Esophagus. 2011; 24(4):258–264.
34. Fushimi H, Kikui M, Morino H, et al. Histologic changes in small cell lung carcinoma after treatment. Cancer. 1996;77(2):278–283.
35. Hage R, Elbers JR, Brutel de la Rivière A, van den Bosch JM. Surgery for combined type small cell lung carcinoma. Thorax. 1998;53(6):450–453.
36. Wang SY, Mao WM, Du XH, Xu YP, Zhang SZ. The 2002 AJCC TNM classification is a better predictor of primary small cell esophageal carcinoma outcome than the VALSG staging system. Chin J Cancer. 2013;32(6):342–352.
37. Ho KJ, Herrera GA, Jones JM, Alexander CB. Small cell carcinoma of the esophagus: evidence for a unified histogenesis. Hum Pathol. 1984; 15(5):460–468.
38. Zhu Y, Qiu B, Liu H, et al. Primary small cell carcinoma of the esophagus: review of 64 cases from a single institution. Dis Esophagus. 2014;27(2):152–158.
39. Babakoohi S, Fu P, Yang M, Linden PA, Dowlati A. Combined SCLC clinical and pathologic characteristics. Clin Lung Cancer. 2013;14(2):113–119.